| Metric | Details |
|---|---|
| Entity / Legal Name | EyeCare Partners, LLC |
| Ownership | Warburg Pincus (PE) — recapitalized 2023 |
| S&P / Moody’s Rating | CCC+ / Caa2 (highly leveraged PE recapitalization) |
| Investment Grade Status | Non-Investment Grade — Substantial Risk |
| Sector | Optometry / Vision Care DSO |
| US Location Count | 750+ |
| Cap Rate Range | 7.50–9.00% |
| Typical Lease Term | 5–10 years (NNN) |
| Guarantee Type | EyeCare Partners corporate entity |
| Annual Revenue | ~$1.1B (est., FY2024) |
| Typical Building Size | 2,500–4,500 SF |
| Typical Price Range | $1,500,000–$3,500,000 |
EyeCare Partners Business Overview & NNN Investment Profile
EyeCare Partners is one of the largest optometry and ophthalmology practice management companies in the United States, operating over 750 vision care clinic locations across 18+ states under multiple regional brand names. The Maryland Heights, Missouri-based DSO (Dental Service Organization equivalent in vision care) provides management services to affiliated optometry and ophthalmology practices, consolidating the historically fragmented independent optometry market under a PE-backed roll-up structure. EyeCare Partners was originally backed by FFL Partners and later recapitalized with Warburg Pincus taking the majority position in 2023 through a debt restructuring that significantly impacted the company’s credit profile.
EyeCare Partners vs. MyEyeDr: Two Vision Care DSOs Compared
Two major optometry DSOs generate NNN transaction volume in the US market. EyeCare Partners (CCC+/Caa2) and MyEyeDr (NR/B3) both operate 700+ locations and occupy similar suburban retail corridors. EyeCare Partners’ deeper credit impairment (CCC+ vs. MyEyeDr’s approximate B3 equivalent) typically commands wider cap rates in the market, with investors requiring a 50 to 100 basis point premium for the additional default risk. Location analysis — market demographics, competition from LensCrafters and Walmart Vision, lease term remaining — becomes even more critical at the CCC tier.
EyeCare Partners NNN Lease Structure & Cap Rates
EyeCare Partners NNN leases carry 5 to 10 year initial terms — shorter than dental DSOs — with annual escalations of 2% to 3%. The 2,500 to 4,500 SF inline strip center and power center format is highly accessible and re-tenantable to competing vision or medical uses. Cap rates for EyeCare Partners NNN properties trade between 7.50% and 9.00% as of Q1 2026. The CCC+/Caa2 rating and shorter lease terms command wide spreads. Suburban locations in strong demographic trade areas with long remaining lease terms price closer to 7.50%. Shorter-term assets and secondary markets price above 8.50%.
Is EyeCare Partners investment grade?
No. EyeCare Partners carries CCC+ from S&P and Caa2 from Moody’s following the 2023 PE debt restructuring — the highest credit risk tier. NNN investors should require a significant cap rate premium and conduct thorough location-level due diligence before committing.
What cap rates are EyeCare Partners NNN properties trading at?
EyeCare Partners NNN properties trade at 7.50% to 9.00% as of Q1 2026. The CCC+/Caa2 credit and shorter 5 to 10 year lease terms command wide spreads. Acquisition prices range from $1,500,000 to $3,500,000.
The Only EyeCare Partners NNN Advisor Whose Fee Comes From the Deal, Not From You
In NNN buyer representation, the listing broker pays the cooperating commission.
Find It — We evaluate location demographics, lease term, and re-tenanting viability before you commit due diligence costs on CCC-rated credit.
Exit It / 1031 — Looking to step up from EyeCare Partners to investment-grade healthcare NNN? We source replacement assets and manage the full 1031 timeline.
Talk to a Healthcare NNN Specialist →
In a 1031 exchange? Tell us your timeline — we move faster.
Related NNN Tenants
- Ascension
- Aspen Dental
- Athletico
- BioLife Plasma
- Concentra / Humana
- Corewell Health
- CSL Plasma
- DaVita Dialysis
- Fresenius
- Grifols
- Henry Ford Health
- HCA Healthcare
- Heartland Dental
- Mary Washington Healthcare
- McLaren Health Care
- Oak Street Health
- Piedmont Healthcare
- Sparrow Health
- Trinity Health
- U of M Health
- University of Pittsburgh Medical Center (UPMC)
- Acadia Healthcare
- AFC Urgent Care
- ATI Physical Therapy
- CityMD / Summit Health
- Encompass Health
- Fast Pace Urgent Care
- MedExpress Urgent Care
- MyEyeDr
- NextCare Urgent Care
- Octapharma Plasma
- Pacific Dental Services
- Select Physical Therapy
- Smile Brands
- VCA Animal Hospitals
- WellNow Urgent Care
- Banfield Pet Hospital
- Labcorp
- National Vision
- Quest Diagnostics
Own a EyeCare Partners Property? Capital Markets Strategies Beyond Selling
Maturing debt and considering refinancing? Our capital markets team maintains 150+ lender relationships underwriting NNN properties across investment-grade and non-investment-grade credit tiers. We structure rate-and-term refinancing, cash-out refis, and bridge-to-perm takeouts.
Evaluating a 1031 exchange or disposition? We represent both sides of EyeCare Partners NNN transactions — whether you are looking to exit at peak value, exchange into a higher-quality credit tenant, or reposition within the same sector.
Need a current valuation? We maintain live comps on EyeCare Partners NNN transactions and can produce a Broker Opinion of Value within 48 hours reflecting today’s cap rate market.
Own multiple EyeCare Partners properties? Considering an off-market sale?
Investment Grade represents owners on confidential disposition of EyeCare Partners portfolios and individual properties through off-market direct-to-principal distribution to specialty REITs, private equity funds, and family offices. EyeCare Partners buyer demand runs deep, and portfolio sales consistently produce stronger pricing than sequential individual sales because the institutional buyer pool is structured around portfolio acquisition.
For multi-property owners considering a portfolio disposition, see Selling Investment Grade NNN Off-Market: Tenant-by-Tenant Buyer Demand. For the full off-market framework covering individual property dispositions, sale-leasebacks, and 1031 coordination, see Off-Market CRE Sales: The Complete 2026 Guide.
The pre-listing conversation is at no cost and fully confidential. Email team@investmentgrade.com or see contact Investment Grade.


